Divi's Laboratories Q2 Results
- BSE: 532488
- NSE: DIVISLAB
- ISIN: INE361B01024
- Sector: Biotechnology & Drugs
BSE
6,186.50
32.75 (0.53%)
32.75 (0.53%)Volume30.81 K
Updated: Tue 17 Feb, 2026 | 15:03:06
NSE
6,164.5015.00 (0.24%)
15.00 (0.24%)Volume1.31 L
Updated: Tue 17 Feb, 2026 | 14:52:42
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Divi's Laboratories Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 1,940.00 | 1,793.00 | 8.20% | 1,721.00 | 12.73% |
| Depreciation/ Amortization | 113.00 | 112.00 | 0.89% | 99.00 | 14.14% |
| Operating Income | 775.00 | 617.00 | 25.61% | 617.00 | 25.61% |
| Net Income | 689.00 | 545.00 | 26.42% | 510.00 | 35.10% |
| Other Operating Expenses Total | 400.00 | 385.00 | 3.90% | 349.00 | 14.61% |
| Net Income Before Taxes | 912.00 | 733.00 | 24.42% | 722.00 | 26.32% |
| Total Revenue | 2,715.00 | 2,410.00 | 12.66% | 2,338.00 | 16.12% |
| Selling/ General/ Admin Expenses Total | 354.00 | 340.00 | 4.12% | 304.00 | 16.45% |
| Diluted Normalized EPS | 25.97 | 20.57 | 26.28% | 19.20 | 35.26% |